126728-71-0|SF 2575|SF 2575|-范德生物科技公司

SF 2575

NMR下载 COA and HPLC MSDS下载
names：
SF 2575
CAS号：
126728-71-0
MDL Number：
MF(分子式)： C40H43NO15 MW(分子量)： 777.776
EINECS: Reaxys Number:
Pubchem ID: Brand:BIOFOUNT

货品编码	规格	纯度	价格 (¥)	现价(¥)	特价(¥)	库存描述	数量	总计 (¥)

大包装询价提供各种包装，敬请垂询
收藏商品商品点评加入购物车立即购买

快速询价

收起

你想询价的产品

*产品名称：

CAS号：

产品编号：

需求描述：

请准确填写您的联系方式，以便为您提供最好的服务。

*公司名称：

*电子邮箱：

联系人：

*电话：

*验证码：

询价

中文别名	Benzoic acid, 2-hydroxy-, 3-(aminocarbonyl)-8-(2,6-dideoxy-4-O-(2-methyl-1-oxo-2-butenyl)-beta-D-arabino-hexopyranosyl)-1,4,4a,6,11,11a,12,12a-octahydro-2,5,7-trihydroxy-4a,11-dimethoxy-11-methyl-4,6-dioxo-1-naphthacenyl ester, (1R-(1-alpha,4a-alpha,11-beta,11a-beta,12a-beta))-
英文别名	SF 2575; SF2575; SF-2575
CAS号	126728-71-0
SMILES	O=C(O[C@@H]1C(O)=C(C(N)=O)C([C@@]2(OC)C(O)=C3C(C4=C([C@@](C)(OC)[C@]3([H])C[C@@]21[H])C=CC([C@H]5C[C@H]([C@@H]([C@@H](C)O5)OC(/C(C)=C/C)=O)O)=C4O)=O)=O)C6=CC=CC=C6O
Inchi	InChI=1S/C40H43NO15/c1-7-16(2)37(50)55-32-17(3)54-25(15-24(32)43)19-12-13-20-26(29(19)44)30(45)27-21(39(20,4)52-5)14-22-33(56-38(51)18-10-8-9-11-23(18)42)31(46)28(36(41)49)35(48)40(22,53-6)34(27)47/h7-13,17,21-22,24-25,32-33,42-44,46-47H,14-15H2,1-6H3,(H2,41,49)/b16-7+/t17-,21-,22-,24-,25-,32-,33+,39-,40+/m1/s1
InchiKey	MPBVFNYOBQUJEJ-GNOOZHHESA-N
分子式 Formula	C40H43NO15
分子量 Molecular Weight	777.776
闪点 FP
熔点 Melting point
沸点 Boiling point
Polarizability极化度
密度 Density
蒸汽压 Vapor Pressure
溶解度Solubility
性状	Solid powder
储藏条件 Storage conditions	Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years).

产品说明	SF 2575(CAS:126728-71-0):仅限应用于工业或者科学研究过程中非医疗目的，不应用于人类或动物的临床诊断以及治过程疗，该产品非药用，非食用。
Introduction	SF 2575 is an anticancer tetracycline.
Application1
Application2
Application3

警示图
危险性	Warning
危险性警示
安全声明
安全防护
备注

[1]Li L, Wang P, Tang Y. C-glycosylation of anhydrotetracycline scaffold with SsfS6 from the SF2575 biosynthetic pathway. J Antibiot (Tokyo). 2014 Jan;67(1):65-70. doi: 10.1038/ja.2013.88. Epub 2013 Sep 1[1]PubMed PMID: 24022606.

[2]Wang F, Zhou M, Singh S, Yennamalli RM, Bingman CA, Thorson JS, Phillips GN Jr. Crystal structure of SsfS6, the putative C-glycosyltransferase involved in SF2575 biosynthesis. Proteins. 2013 Jul;81(7):1277-82. doi: 10.1002/prot.24289. Epub 2013 Apr 20. PubMed PMID: 23526584; PubMed Central PMCID: PMC3896073.

[3] Wang P, Kim W, Pickens LB, Gao X, Tang Y. Heterologous expression and manipulation of three tetracycline biosynthetic pathways. Angew Chem Int Ed Engl. 2012 Oct 29;51(44):11136-40. doi: 10.1002/anie.201205426. Epub 2012 Sep 28. PubMed PMID: 23024027; PubMed Central PMCID: PMC4070387.

[4] Pickens LB, Sawaya MR, Rasool H, Pashkov I, Yeates TO, Tang Y. Structural and biochemical characterization of the salicylyl-acyltranferase SsfX3 from a tetracycline biosynthetic pathway. J Biol Chem. 2011 Dec 2;286(48):41539-51. doi: 10.1074/jbc.M111.299859. Epub 2011 Sep 29. PubMed PMID: 21965680; PubMed Central PMCID: PMC3308865.

[5] Hatsu M, Sasaki T, Gomi S, Kodama Y, Sezaki M, Inouye S, Kondo S. A new tetracycline antibiotic with antitumor activity. II. The structural elucidation of SF2575. J Antibiot (Tokyo). 1992 Mar;45(3):325-30. PubMed PMID: 1577661.

6: Pickens LB, Kim W, Wang P, Zhou H, Watanabe K, Gomi S, Tang Y. Biochemical analysis of the biosynthetic pathway of an anticancer tetracycline SF2575. J Am Chem Soc. 2009 Dec 9;131(48):17677-89. doi: 10.1021/ja907852c. PubMed PMID: 19908837; PubMed Central PMCID: PMC2800175.7: Hatsu M, Sasaki T, Watabe H, Miyadoh S, Nagasawa M, Shomura T, Sezaki M, Inouye S, Kondo S. A new tetracycline antibiotic with antitumor activity. I. Taxonomy and fermentation of the producing strain, isolation and characterization of SF2575. J Antibiot (Tokyo). 1992 Mar;45(3):320-4. PubMed PMID: 1577660.

对不起，暂无产品评价！

MSDS

SDS 1.0 中文

展开

SDS 1.0 英文

展开